Effects of testosterone enanthate in normal men: Experience from a multicenter contraceptive efficacy study

Fertility and Sterility

Volumn 65, Issue 3, 1996, Pages 626-636

  Wu, F C W ^a   Waites, G M H ^a   Farley, T M M ^a   Peregoudov, A ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

family planning; hormonal contraception; male contraception; pharmacodynamics; pharmacology; safety; testis; Testosterone enanthate

Indexed keywords

AMINOTRANSFERASE; CHOLESTEROL; CREATININE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE ENANTATE; TRIACYLGLYCEROL; UREA;

ACNE; ADULT; ARTICLE; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; GYNECOMASTIA; HORMONAL CONTRACEPTION; HORMONAL THERAPY; HUMAN; HUMAN EXPERIMENT; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; LIPID METABOLISM; MALE; MULTICENTER STUDY; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE DISEASE; TESTIS SIZE; WEIGHT GAIN;

EID: 0030051419     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(16)58166-7     Document Type: Article

References (24)

1. World Health Organization Task Force for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men Lancet 336 1990 955 959
2. S. Bhasin Androgen treatment of hypogonadal men J Clin Endocrinol Metab 74 1992 1221 1225
3. D.J. Patanelli Hormonal control of fertility 1978 US Department of Health Education and Welfare Washington (DC) Publication No. (NIH)78-1097.
4. W.T. Friedwald R.I. Levy D.S. Frederickson Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of preparative ultra-centrifugation Clin Chem 16 1972 499 502
5. R.S. Swerdloff A. Palacios R.D. McClure L.A. Campfield S.A. Brosman Male contraception: clinical assessment of chronic administration of testosterone enanthate Int J Androl Suppl 2 1978 731 745
6. H.M. Behre F. Oberpenning E. Nieschlag Comparative pharmacokinetics of androgen preparations: application of computer analysis and simulation E. Nieschlag H.M. Behre Testosterone action deficiency substitution 1990 Springer-Verlag Berlin 115 135
7. D.J. Handelsman A.J. Conway L.M. Boylan Suppression of human spermatogenesis by testosterone implants in man J Clin Endocrinol Metab 75 1992 1326 1332
8. N.R. Young H.W.G. Baker Guangda Liu E. Seeman Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception J Clin Endocrinol Metab 77 1994 1028 1032
9. G. Forbes The effects of anabolic steroids on lean body mass: the dose response curve Metabolism 34 1985 571 573
10. R.A. Anderson J. Bancroft F.C.W. Wu The effects of exogenous testosterone on sexuality and mood of normal men J Clin Endocrinol Metab 75 1992 1503 1507
11. P.D. Thompson E.M. Cullinane S.P. Sady C. Chenevert A.L. Sari-telli M.A. Sady Contrasting effects of testosterone and stanozolol on serum lipoprotein levels J Am Med Assoc 261 1989 1165 1168
12. C.J. Bagatell J.R. Heiman A.M. Matsumoto J.E. Rivier W.J. Bremner Metabolic and behaviour effects of high dose exogenous testosterone (T) in normal men J Clin Endocrinol Metab 79 1994 561 567
13. K.E. Friedl C.H. Hannan R.E. Jones S.R. Plymate High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered Metabolism 39 1990 69 74
14. R. Sorva T. Kuusi M-R. Taskinen J. Perheentupa E.A. Nikkila Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males Atherosclerosis 69 1988 191 197
15. G.J. Miller N.E. Miller Plasma high-density-lipoprotein concentration and development of ischaemic heart disease Lancet 1 1975 16 19
16. D.J. Gordon B.M. Rifkind High-density lipoprotein—the clinical implications of recent studies N Engl J Med 321 1989 1311 1316
17. E. Barrett-Connor Androgens, lipids and atherosclerosis S. Bhasin R.S. Swerdloff C. Wang H. Gabelnick J. Spieler Pharmacology, biology and clinical applications of androgens 1995 Wiley New York In press.
18. H.S. Jacobs F.E. Loeffler Postmenopausal hormone replacement therapy Br Med J 305 1992 1403 1408
19. E.M. Wallace S.D. Pye S.R. Wild F.C.W. Wu Prostate-specific antigen and prostate gland size in men receiving exogenous testosterone for male contraception Int J Androl 16 1993 35 40
20. G.J. Gormley E. Stoner R.C. Bruskewitz J. Imperato-McGinley P.C. Walsh J.D. McConnell The effect of finasteride in men with benign prostatic hyperplasia N Engl J Med 327 1992 1185 1191
21. D.J. Handelsman T.M.M. Farley A. Peregoudov G.M.H. Waites World Health Organization Task Force on Methods for the Regulation of Male Fertility Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men Fertil Steril 63 1995 125 133
22. H.M. Behre E. Nieschlag Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester J Clin Endocrinol Metab 75 1992 1204 1210
23. S.N. Pavlou K. Brewer M.G. Farley J. Lindner M.C. Bastia B.J. Rogers Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido J Clin Endocrinol Metab 73 1991 1360 1369
24. World Health Organization Task Force on Methods for the Regulation of Male Fertility Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in Indonesian men Fertil Steril 60 1993 1062 1068